Galaxy Medicare opened higher at ₹18.20, compared with its previous close of ₹17.45. During today's session, the stock has traded between ₹17.00 and ₹18.25, with an average traded price of ₹17.81. It is currently showing an upward intraday trend.
An investment of ₹10,000 made 2 years ago in Galaxy Medicare is now worth
₹ 3,558.00
resulting in a loss of
₹ 6,442.00 (64.42%)
Note: Past profits do not guarantee future returns.
No analyst rating data available.
Today's Change
+0.80 (+4.58%)
Day High
₹18.25
Day Low
₹17.00
Day Open
₹18.20
Prev Close
₹17.45
Volume
6,000
Value Traded
₹0.01 Cr
1W Return
2.65%
1M Return
7.99%
3M Return
-2.93%
6M Return
-6.41%
1Y Return
-14.72%
Market Cap (₹ Cr.)
28
PE Ratio
7.80
PB Ratio
0.76
Dividend Yield
4.01%
ROE
8.47%
ROCE
12.01%
Book Value (₹)
22.83
Face Value (₹)
10.00
EPS (TTM)
-
Industry PE
-
Beta
-
Debt to Equity
-
1 Week
2.65%
6 Week
-
1 Month
7.99%
3 Month
-2.93%
9 Month
-10.76%
No data available.
Galaxy Medicare confirms no encumbrance on promoter shares in FY26
Galaxy Medicare Limited filed a disclosure with the NSE confirming that its promoters and promoter group held no encumbrance on shares for the financial year ended March 31, 2026. The declaration, signed by Subhasish Das, covers 15 entities including individuals and corporate bodies, verifying that no shares were pledged or invoked. This compliance with SEBI Regulation 31(4) assures investors of the unencumbered status of the promoter's holding.
3mo agoGalaxy Medicare FY26 net profit rises to ₹341.81 lakh
Galaxy Medicare Limited reported a net profit of ₹341.81 lakh for the financial year ended March 31, 2026, compared to ₹337.05 lakh in the previous year. Revenue from operations for FY26 stood at ₹4,000.33 lakh, a marginal increase from ₹3,920.16 lakh in FY25. The board approved the audited financial results and recommended a final dividend of ₹0.35 per equity share, subject to shareholder approval. The statutory auditors issued an unmodified opinion but noted an advance payment of ₹50 lakh to the IPO Book Running Lead Manager pending adjustment. The board also approved the re-appointment of key directors, including Mr. Dillip Kumar Das as Managing Director, and re-appointed M/s. Saroj Ray & Associates as Secretarial Auditor.
4mo agoGalaxy Medicare Signs ₹19.45 Cr Agreement with Odisha Government for Manufacturing Unit in Khordha
Galaxy Medicare Limited has signed an agreement with the Odisha government to establish a new pharmaceutical and medical devices manufacturing facility in Khordha district. The company has committed to invest ₹19.45 crores in this project, which will focus on producing pharmaceuticals and medical devices. This move marks Galaxy Medicare's expansion into eastern India and is expected to enhance its production capacity and market position.
9mo ago| Stock | LTP | Change % | Market Cap (Cr.) | PE | 1Y Return |
|---|---|---|---|---|---|
| ₹1,600.00 | -2.51% | ₹16,217.83 | 53.25 | -15.61% | |
| ₹336.75 | +1.89% | ₹1,791.72 | 158.06 | +12.81% | |
| ₹601.75 | -0.50% | ₹1,403.77 | 25.31 | +75.44% | |
| ₹195.94 | +0.12% | ₹1,078.25 | 34.93 | -38.46% | |
| ₹460.05 | -2.26% | ₹804.79 | 72.30 | -21.71% | |
| ₹360.20 | +0.92% | ₹640.96 | 21.74 | -41.89% | |
| ₹137.03 | +4.41% | ₹609.11 | 12.00 | -29.67% | |
| ₹178.87 | -2.81% | ₹345.89 | 28.27 | +67.72% | |
| ₹323.40 | -2.41% | ₹308.59 | 73.19 | +39.20% | |
| ₹97.85 | -10.23% | ₹186.31 | 40.52 | -60.13% | |
| ₹170.00 | -3.95% | ₹178.73 | 20.70 | -37.04% | |
| ₹31.30 | -0.16% | ₹57.08 | -3.43 | +0.00% |
An investment of ₹10,000 made 2 years ago in Galaxy Medicare is now worth
₹ 3,558.00
resulting in a loss of
₹ 6,442.00 (64.42%)
Note: Past profits do not guarantee future returns.
